期刊文献+

中老年男性2型糖尿病合并骨质疏松患者骨转换标志物的变化 被引量:15

Change of biochemical bone turnover markers in the middle-aged and elderly men with type 2 diabetes mellitus and osteoporosis
下载PDF
导出
摘要 目的探讨中老年男性2型糖尿病合并骨质疏松患者骨转换标志物的变化及其相关因素。方法选取80例中老年男性患者,根据1998年世界卫生组织(WHO)骨质疏松诊断标准和1999年WHO糖尿病诊断标准,分为骨质疏松(OP)组40例,糖尿病性骨质疏松(DOP)组40例。分别测定受试者的骨转换标志物、血钙、磷、甲状旁腺激素、25羟维生素D(25OHD)及糖代谢等相关指标。采用SPSS 22.0统计软件进行分析。依据数据类型,分别进行t检验、Pearson线性相关分析及多元逐步回归分析。结果两组相比,L1-4[(0. 960±0. 281) vs (0. 970±0. 126) g/cm^2,P=0. 22]、股骨颈[(0. 895±0. 162) vs(0. 895±0. 119) g/cm^2,P=0. 99)]和全髋部[(0. 784±0. 143) vs (0. 748±0. 112) g/cm^2,P=0. 85)]骨密度均无明显差异。与OP组相比,DOP组骨钙素(OC)[(16. 69±8. 91) vs (22. 71±13. 12) ng/ml,P=0. 019]、P1NP [(43. 04±20. 29) vs(53. 64±24. 08) ng/ml,P=0. 037]、25OHD[(12. 80±5. 5) vs (16. 58±8. 00) ng/ml,P=0. 044)]降低,CTX[(0. 64±0. 22) vs(0. 49±0. 30) ng/ml,P=0. 013]升高,差异均有统计学意义。相关分析显示,OC、P1NP均与Hb A1c、病程呈负相关,CTX与Hb A1c、病程呈正相关,与全髋部骨密度呈负相关(P<0. 05)。回归分析显示,Hb A1c是OC、P1NP的独立相关因素,CTX除受Hb A1c的影响外,还受全髋部骨密度的影响。结论 2型糖尿病患者骨形成降低,骨吸收增加,且随着血糖的恶化、病程的进展逐步加重。2型糖尿病合并骨质疏松患者维生素D缺乏更严重。 Objective To investigate bone turnover markers and associated factors in the middle-aged and elderly men with type 2 diabetes mellitus(T2DM)and osteoporosis.Methods According to the 1998 WHO diagnostic criteria for osteoporosis and the 1990 WHO diagnostic criteria for diabetes,80 middle-aged and elderly men were divided into osteoporosis group(OP,n=40)and diabetic osteoporosis group(DOP,n=40).All the patients received tests for bone turnover markers,serum calcium(Ca),serum phosphor(P),parathyroid hormone(PTH),25-OH vitamin D(25OHD)and other biomarkers of glucose metabolism.Statistical analysis was done using SPSS statistics 22.0.Depending on data type,Student′s t test,Pearson linear correlation or multivariate regression was performed.Results There were no obvious differences between the OP and DOP groups in BMD of L 1-4[(0.960±0.281)vs(0.970±0.126)g/cm 2,P=0.22],femoral neck[(0.895±0.162)vs(0.895±0.119)g/cm 2,P=0.99]and total hip[(0.784±0.143)vs(0.748±0.112)g/cm 2,P=0.85].Compared with OP group,DOP group had lower osteocalcin(OC)[(16.69±8.91)vs(22.71±13.12)ng/ml,P=0.019],P1NP[(43.04±20.29)vs(53.64±24.08)ng/ml,P=0.037]and 25OHD[(12.80±5.54)vs(16.58±8.00)ng/ml,P=0.044],but higher CTX[(0.64±0.22)vs(0.49±0.30)ng/ml,P=0.013],the differences being statistically significant.Correlation analysis found that OC and P1NP were negatively correlated with HbA1c and the duration of diabetes,and that CTX was positively correlated with HbA1c and the duration of diabetes but negatively correlated with BMD of total hip(P<0.05).Regression analysis showed that HbA1c was an independent risk factor for OC and P1NP,and that CTX was affected by HbA1c and BMD of total hip.Conclusion Patients with T2DM have decreased bone formation and increased bone absorption which was gradually exacerbated with the deterioration of blood glucose and progression of diabetes.Vitamin D deficiency is worse in patients with diabetic osteoporosis.
作者 朱慧静 杨明明 朱昕 王惠丽 程霖 成兴波 裴育 ZHU Hui-Jing;YANG Ming-Ming;ZHU Xin;WANG Hui-Li;CHENG Lin;CHENG Xing-Bo;PEI Yu(Department of Endocrinology&Metabolism,Affiliated First Hospital of Soochow University,Suzhou 215006,China;Department of Endocrinology&Metabolism,Heze Municipal Hospital,Heze 274000,China;;Department of Endocrinology&Metabolism,Chinese PLA General Hospital,Beijing 100853,China)
出处 《中华老年多器官疾病杂志》 2018年第12期906-910,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 骨转换标志物 2型糖尿病 骨质疏松 男性 bone turnover marker type 2 diabetes mellitus osteoporosis male
  • 相关文献

参考文献5

二级参考文献148

  • 1刘红,廖二元,伍贤平,张红,罗湘杭,谢辉,曹行之,刘石平.正常女性与年龄相关的骨转换生化指标和骨密度的关系[J].中华内科杂志,2004,43(11):805-809. 被引量:27
  • 2李慧林,朱汉民,程群,陈小平,朱晓颖,张雪梅.绝经妇女绝经后年限及年龄与骨量丢失率关系[J].中国骨质疏松杂志,2007,13(7):502-504. 被引量:25
  • 3Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis[ J]. Exp Clin Endocrinol Diabetes, 2001, 109 (Suppl 2) : S493-S514.
  • 4Hernandez MV, Guanabens N, Alvarez L, et al. Immunocy- tochemical evidence on the effects of glucocorticoids on type 1 collagen synthesis in human osteoblastic cells [ J ]. Calcif Tissue Int, 2004, 74(3) : 284-293.
  • 5Duarte VM, Ramos AM, Rezende LA, et al. Osteopenia : a bone disorder associated with diabetes mellitus [ J ]. J Bone Miner Metab, 2005, 23( 1 ) : 58-68.
  • 6Raska I Jr, Broulik P. The impact of diabetes mellitus on skeletal health: an established phenomenon with inestab- lished causes [ J]. Prague Med Rep, 2005, 106 (2) : 137-148.
  • 7Lu H, Kraut D, Gerstenfeld LC, et al. Diabetes interferes with the bone formation by affecting the expression of tran- scription factors that regulate osteoblast differentiation [ J ]. Endocrinology, 2003, 144 ( 1 ) : 346-352.
  • 8Isaia GC, Ardissone P, Di SM, et al. Bone metabolism in type 2 diabetes mellitus [ J]. Acta Diabetol, 1999, 36 ( 1/ 2) : 35-38.
  • 9Kumeda Y, Inaba M, Nishizawa Y. Secondary osteoporosis and its treatment-diabetes mellitus [ J ]. Nihon Rinsho, 1998, 56(6) : 1579-1586.
  • 10邱明才,戴晨琳.代谢性骨病学[M].北京:人民卫生出版社,2012:9305.

共引文献1502

同被引文献164

引证文献15

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部